Skip to main content
INM logo

INM · InMed Pharmaceuticals Inc. · Executive Compensation

Track INM — free
$1.33 -0.02 (-1.48%) At close · Oct 2
Market Cap
$7.58M
Shares
5.49M
Volume · Oct 2 28.34K Avg daily vol (3M) 916.81K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
John Bathery Appointed 2025-10-16
Neil Klompas Appointed 2025-10-14
Janet Grove Resigned 2025-02-14
Netta Jagpal Appointed 2024-02-09
Jonathan Tegge Resigned 2024-02-09
N. Netta "Neeta" Jagpal Appointed 2024-02-09
Jonathan Tegge Appointed 2022-12-13
Sarah Li Appointed 2022-11-17
Brenda Edwards Terminated 2022-11-17
Nicole Lemerond Appointed 2022-08-11
Adam Cutler Resigned 2022-08-11
Michael Woudenberg Appointed 2022-07-20
Michael Woudenberg Appointed 2022-07-20
Key facts CIK 1728328 CUSIP 457637700 Visit website Investor relations